Cost-effectiveness and cost-utility of population-based glaucoma screening in China: a decision-analytic Markov model.

Tang J, Liang Y, O'Neill C, Kee F, Jiang J, Congdon N

Open source

DOI
10.1016/s2214-109x(19)30201-3
Published
2019 Jul
Container
The Lancet. Global health
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s2214-109x-19-30201-3,
  title = {Cost-effectiveness and cost-utility of population-based glaucoma screening in China: a decision-analytic Markov model.},
  author = {Tang J and Liang Y and O'Neill C and Kee F and Jiang J and Congdon N},
  year = {2019},
  journal = {The Lancet. Global health},
  doi = {10.1016/s2214-109x(19)30201-3},
  url = {https://doi.org/10.1016/s2214-109x(19)30201-3}
}

RIS

TY  - JOUR
TI  - Cost-effectiveness and cost-utility of population-based glaucoma screening in China: a decision-analytic Markov model.
AU  - Tang J
AU  - Liang Y
AU  - O'Neill C
AU  - Kee F
AU  - Jiang J
AU  - Congdon N
PY  - 2019
JO  - The Lancet. Global health
DO  - 10.1016/s2214-109x(19)30201-3
UR  - https://doi.org/10.1016/s2214-109x(19)30201-3
ER  - 

APA

J, T., Y, L., C, O., F, K., J, J., & N, C. (2019). Cost-effectiveness and cost-utility of population-based glaucoma screening in China: a decision-analytic Markov model.. The Lancet. Global health. https://doi.org/10.1016/s2214-109x(19)30201-3

Source records